期刊文献+

卵巢癌患者呼气中挥发性标志物的筛查 被引量:4

The screening of volatile markers in the breath of ovarian cancer patients
下载PDF
导出
摘要 目的应用固相微萃取联合气相色谱/质谱技术筛查卵巢癌患者呼气中挥发性标志物。方法收集40例卵巢癌患者呼气样本(卵巢癌组),49例健康女性呼气样本(对照组),同时收集周围空气作为参考。利用固相微萃取联用气相色谱/质普检测筛查卵巢癌患者呼气中的挥发性有机化合物。通过t检验分析卵巢癌患者呼气中的特异性挥发性标志物。结果筛选出苯乙烯和壬醛两种特异性挥发性标志物。卵巢癌组苯乙烯的浓度为(268.854±96.660)ng/L,壬醛的浓度为(388.631±122.660)ng/L。两种物质的浓度在卵巢癌组和对照组之间差异有统计学意义(P<0.05)。结论苯乙烯和壬醛可能是卵巢癌患者呼气中潜在挥发性标志物。 Objective To screen the volatile organic compounds (VOCs) in ovarian cancer patients with solid phase micro-extract combined with the gas chromatography (GC)/mass spectrometry (MS). Methods The breath samples were collected from 40 ovarian cancer patients and 49 healthy women as control. Besides, the ambient air was collected for reference. VOCs were extracted with SPME and analyzed by gas Chromatography (GC)/mass spectrometry (MS). The student-t test was used for discriminating the VOCs and assessing the statistical significance. Results Styrene and nonanal were found as the specific VOCs for ovarian. The concentration range of the styrene was (268. 854 ±96. 660) ng/L,and the concentration range of nonanal was (388. 631 ± 122. 660) ng/L. The concentration of the two VOCs molecules were significantly different between ovarian cancer patients and healthy control (P 〈 0. 05). Conclusion Styrene and nonanal may be considered as potential volatile markers for diagnosis of patients with ovarian cancer.
出处 《安徽医科大学学报》 CAS 北大核心 2013年第5期499-501,共3页 Acta Universitatis Medicinalis Anhui
关键词 卵巢癌 挥发性有机化合物 固相微萃取 气相色谱 质谱 ovarian cancer volatile organic compounds solid phase micro-extract gas chromatography/mass spectrometry
  • 相关文献

参考文献12

  • 1Partridge E, Kreimer A R, Greenlee R T,et al. Results from fourrounds of ovarian cancer screening in a randomized trial [ J] . Ob-stet Gynecol, 2009, 113(4) : 775 -82.
  • 2Nossov V,Amneus M, Su F,et al. The early detection of ovariancancer: from traditional methods to proteomics. Can we really dobetter than serum CA-125? [ J]. Am J Obstet Gynecol, 2008 ,199(3) :215 -23.
  • 3Pauling L,Robinson A B, Teranishi R, et al. Quantitative analy-sis of urine vapor and breath by gas-liquid partition chromatography[J]. Proc Natl Acad Sci USA, 1971, 68(10) : 2374 -6.
  • 4Schmutzhard J, Rieder J, Deibl M, et al. Pilot study: Volatile or-ganic organic compounds as a diagnostic marker for head and necktumors [J]. Head Neck, 2008 , 30(6) : 743 -9.
  • 5宋耕,秦涛,刘虎,徐国兵,熊福星,孙国平,顾康生,陈振东.早期肺癌患者呼气中痕量挥发性有机化合物的定量检测[J].安徽医科大学学报,2008,43(3):323-325. 被引量:22
  • 6秦涛,刘虎,高署,宋琪,孙国平,陈振东.肝癌患者呼气中挥发性标志物的筛选与定量分析[J].安徽医科大学学报,2009,44(1):106-109. 被引量:13
  • 7Martinez-Outschoom U E, Balliet R M, Lin Z, et al. Hereditaryovarian cancer and two-compartment tumor metabolism : epithelialloss of BRCA1 induces hydrogen peroxide production,driving oxi-dative stress and NF kB activation in the tumor stroma [ J ]. Cell Cycle,2012,11(22):4152 -66.
  • 8Klaunig J E, Wang Z, Pu X,et al. Oxidative stress and oxidativedamage in chemical carcinogenesis [ J]. Toxicol Appl Pharmacol,2011,254(2) :86 -99.
  • 9Kneepkens C M, Lepage G, Roy C C. The potential of the hydro-carbon breath test as a measure of lipid peroxidation [ J] . FreeRadic Biol Med, 1994, 17(2) : 127 -60.
  • 10Birben E, Sahiner U M, Sackesen C, et al. Oxidative stress andantioxidant defense [ J]. World Allergy Organ J, 2012,5(1):9-19.

二级参考文献17

  • 1Pauling L, Robinson A B, Teranishi R, et al. Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography [J]. Proc Natl Acad Sci USA,1971,68(10) :2374 -6.
  • 2Phillips M,Herrera J, Krishnan S,et al. Variation in volatile organic compounds in the breath of normal humans[ J]. J Chromatogr B Biomed Sci Appl, 1999,729 ( 1-2 ) :75 - 88.
  • 3Miekisch W,Schubert J K, Noeldge-Schomburg G F E. Diagnostic potential of breath analysis-focus on volatile organic compounds [ J]. Clin Chim Acta,2004,347 (1-2 ) :25 -39.
  • 4Phillips M, Gleeson K, Hughes J M, et al. Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study [J]. Lancet, 1999,353 (9168) :1930 -3.
  • 5Phillips M, Cataneo R N, Ditkoff B A, et al. Volatile markers of breast cancer in the breath [ J ]. The breast journal, 2003,9 ( 3 ) : 184 -91.
  • 6Schmutzhard J, Rieder J, Deibl M, et al. Pilot study : Volatile organic compounds as a diagnostic marker for head and neck tumors [ J ]. Head Neck,2008,30 (6) :743 - 9.
  • 7Phillips M,Altorki N,Austin J H, et al. Prediction of lung cancer using volatile biomarkers in breath [ J ]. Cancer Biomark, 2007,3 (2) :95 - 109.
  • 8Wolfram M, Jochen K, Gabriele F E, et al. Diagnostic potential of breath analysis-focus on volatile organic compounds [ J ]. Clin Chim Acta, 2004,347( 1 ) :25 -39.
  • 9Hietanen E, Bartsch H, Bereziat J C, et al. Diet and oxidative stress in breast, colon and prostate cancer patients: a case-control study[J]. Eur J Clin Nutr, 1994,48(8) :575 -86.
  • 10Mamett L J. Oxyradicals and DNA damage [ J ]. Carcinogenesis, 2000,21(3) :361-70.

共引文献28

同被引文献28

  • 1Jemal A, Bray F, Center M M, et al. Global cancer statistics [J].CA Cancer J Clin, 2011,61(2):69 -90.
  • 2Schnmutzhard J, Rieder J, Deibl M, et al. Piolt study: Volatile organic compounds as a diagnostic marker for head and neck tumors [J]. Head Neck, 2008, 30(6) :743 -9.
  • 3Miekisch W, Schubert J K, Noeldge-Schomburg G F. Diagnostic potential of breath analysis-focus on volatile organic compounds [J]. Clin Chim Acta, 2004, 347(1 -2) :25 -39.
  • 4Peng G, Tisch U, Adams O, et al. Diagnosing lung cancer in ex- haled breath using gold nanoparticles [ J ]. Nat Nanotechnol, 2009, 4(10) :669 -73.
  • 5Peng G, Hakim M, Haick H, et al. Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors [J]. Br J Cancer, 2010, 103(4) :542 - 51.
  • 6Xu Z Q, Broza Y Y, Ionsecu R, et al. A nanomaterial-based breath test for distinguishing gastric cancer from benign gastric conditions [J]. BrJCancer, 2013, 108(4): 941 -50.
  • 7Amal H, Ding L, Liu B B,et al. The scent fingerprint of hepato- carcinoma: in-vitro metastasis prediction with volatile organic compounds[ J]. Int J Nanomedicine,2012, 7:4135 -46.
  • 8Garnet L. Anderson,Martin McIntosh,Lieling Wu,Matt Barnett,Gary Goodman,Jason D. Thorpe,Lindsay Bergan,Mark D. Thornquist,Nathalie Scholler,Nam Kim,Kathy O’Briant,Charles Drescher,Nicole Urb.Assessing Lead Time of Selected Ovarian Cancer Biomarkers: A Nested Case–Control Study. Journal of the National Cancer Institute . 2010
  • 9石大友.卵巢癌患者呼气中挥发性标志物的筛查与定量分析[D].安徽医科大学2013
  • 10Byong Yoo,Sun-Young Kong,Sang-Geun Jang,Kyung-Hee Kim,Sun-A Ahn,Weon-Seo Park,Sohee Park,Tak Yun,Hyeon-Seok Eom.Identification of hypoxanthine as a urine marker for non-Hodgkin lymphoma by low-mass-ion profiling. BMC Cancer . 2010

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部